Valuation: PolyNovo Limited

Market Cap 656M 455M 398M 365M 340M 645M 43.31B 4.4B 1.7B 21.24B 1.71B 1.67B 73.2B P/E 2026 *
87.7x
P/E 2027 * 33.7x
Enterprise Value 631M 437M 382M 351M 327M 620M 41.63B 4.22B 1.64B 20.42B 1.64B 1.61B 70.35B EV / Sales 2026 *
4.16x
EV / Sales 2027 * 3.39x
Free-Float
88.97%
Yield 2026 *
-
Yield 2027 * -
1 day+3.16%
1 week+7.69%
Current month+6.52%
1 month-8.84%
3 months+5.95%
6 months-20.00%
Current year-20.33%
1 week 0.9
Extreme 0.905
0.99
1 month 0.9
Extreme 0.905
1.1
Current year 0.86
Extreme 0.865
1.3
1 year 0.86
Extreme 0.865
1.66
3 years 0.86
Extreme 0.865
2.78
5 years 0.84
Extreme 0.835
2.78
10 years 0.17
Extreme 0.17
4.08
Manager TitleAgeSince
Chief Executive Officer - 2025-11-30
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman - 2025-10-26
Director/Board Member 65 2019-10-27
Director/Board Member - 2020-05-12
Date Insider Type Main position Quantity % Market Cap.
03-15Buy

Director

151,000 0.0219%
02-26Buy

Director

100,000 0.0145%
02-26Buy

Chairman

30,000 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+3.16%+7.69%-17.99%-35.53% 455M
+3.49%+2.32%-28.86%-12.49% 166B
+5.04%+3.32%-5.77%-5.57% 106B
+2.80%+3.33%+1.83%+54.09% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.2B
+3.39%+4.43%-10.83%-40.12% 43.56B
+3.50%+14.35% - - 36.52B
+3.47%+3.79%-14.75%-44.56% 27.49B
+0.20%+5.53%+65.33%-4.37% 25.84B
+2.78%+3.61%-8.42%-3.01% 21.27B
Average +2.92%+3.78%+3.75%-4.64% 53.87B
Weighted average by Cap. +3.31%+3.29%-3.69%-0.13%

Financials

2026 *2027 *
Net sales 152M 105M 91.81M 84.31M 78.62M 149M 10B 1.02B 393M 4.91B 395M 386M 16.91B 181M 126M 110M 101M 94.12M 178M 11.97B 1.22B 471M 5.87B 472M 462M 20.24B
Net income 7.01M 4.86M 4.25M 3.9M 3.64M 6.9M 463M 46.97M 18.2M 227M 18.26M 17.86M 782M 19.31M 13.39M 11.7M 10.74M 10.02M 18.99M 1.27B 129M 50.12M 625M 50.26M 49.17M 2.15B
Net Debt -25.56M -17.72M -15.48M -14.22M -13.26M -25.14M -1.69B -171M -66.35M -827M -66.54M -65.09M -2.85B -41.66M -28.88M -25.23M -23.17M -21.61M -40.96M -2.75B -279M -108M -1.35B -108M -106M -4.65B
Logo PolyNovo Limited
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.
Employees
301
Date Price Change Volume
26-07-03 A$0.9800 +3.16% 2,065,059
26-07-02 A$0.9500 +1.60% 1,328,704
26-07-01 A$0.9350 +1.63% 1,861,960
26-06-30 A$0.9200 -0.54% 3,846,576
26-06-29 A$0.9250 +1.65% 1,266,658
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
0.9500AUD
Average target price
1.705AUD
Spread / Average Target
+79.46%

Quarterly revenue - Rate of surprise